TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3%
Fri, 1 Nov

TORRENT PHARMA has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

TORRENT PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-18*
3
Jun-19*
3
Sep-19*
QoQ ChangeYoY Change
Net SalesRs m18,94020,22020,050-0.8%5.9%
Other incomeRs m10020034070.0%240.0%
TurnoverRs m19,04020,42020,390-0.1%7.1%
ExpensesRs m14,21014,81014,640-1.1%3.0%
Gross profitRs m4,7305,4105,4100.0%14.4%
DepreciationRs m1,5201,6001,6301.9%7.2%
InterestRs m1,2601,2201,160-4.9%-7.9%
Profit before taxRs m2,0502,7902,9606.1%44.4%
TaxRs m260630520-17.5%100.0%
Profit after taxRs m1,7902,1602,44013.0%36.3%
Gross profit margin%25.026.827.0
Effective tax rate%12.722.617.6
Net profit margin%9.410.612.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 5.9% on a year-on-year (YoY) basis. The expenses were up by 3.0% YoY during the same period.
  • The company's operating profit increased by 14.4% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.0% in 2QFY20 as against 25.0% in 2QFY19.
  • Depreciation charges increased by 7.2% and finance costs declined by 7.9% YoY, respectively.
  • Other income increased by 240.0% YoY during the quarter.
  • Net profit for the quarter increased by 36.3% YoY. Net profit margins during the quarter increased from 9.4% in 2QFY19 to 12.0% in 2QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 0.8% on a quarter-on-quarter (QoQ) basis. The expenses were down by 1.1% QoQ during the same period.
  • The company's operating profit increased by 0.0% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.0% in 2QFY20 as against 26.8% in 1QFY19.
  • Net profit for the quarter increased by 13.0% QoQ, while net profit margins increased from 10.6% in 1QFY19 to 12.0% in 2QFY20.

To see how TORRENT PHARMA has performed over the last eight quarters,please visit here.

FREE: Tanushree Banerjee's Controversial Event on Forever Stocks

TORRENT PHARMA Share Price Performance

Over the last one year,TORRENT PHARMA share price has moved up from Rs 1,711.5 to Rs 1,798.1, registering a Gain of Rs 86.7 or around 5.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,321.5 (up 0.7%). Over the last one year it has moved down from 14,632.9 to 13,321.5, a gain of 1,311 points (down 9.0%).

Overall, the S&P BSE SENSEX is up 16.5% over the year.

Current Valuations

At the current price of Rs 1,798.1, the price to earnings (P/E) ratio of TORRENT PHARMA stands at 54.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.6 times.

Equitymaster requests your view! Post a comment on "TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3%". Click here!

  

Related Views on News

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors(Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

My 'Unlock' Investments(Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

The Most Visible Sign of India's Revival is on Two Wheels(Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

Rs 2 Trillion Stimulus Coming to a Stock Market Near You(Profit Hunter)

Jun 2, 2021

Get ready to profit from a massive stimulus that you've never seen before.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Jun 15, 2021 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS